Lataa...
P2Y12-ADP receptor antagonists: Days of future and past
Antiplatelet therapy is the cornerstone of the therapeutic arsenal in coronary artery disease. Thanks to a better understanding in physiology, pharmacology and pharmacogenomics huge progress were made in the field of platelet reactivity inhibition thus allowing the expansion of percutaneous coronary...
Tallennettuna:
| Julkaisussa: | World J Cardiol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4877361/ https://ncbi.nlm.nih.gov/pubmed/27231519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v8.i5.327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|